Reported MRI data from the SCiStar study that indicates AST - OPC1 cells have durably engrafted in patients post-implantation, demonstrating the potential for AST - OPC1 to prevent lesion cavity formation and possibly reducing spinal cord tissue
deterioration after spinal cord injury.